Malignant neoplasm of anterior two-thirds of tongue, part unspecified
ICD-10 C02.3 is a billable code used to indicate a diagnosis of malignant neoplasm of anterior two-thirds of tongue, part unspecified.
C02.3 refers to a malignant neoplasm located in the anterior two-thirds of the tongue, where the specific part of the tongue affected is not specified. This type of cancer is often squamous cell carcinoma, which is the most common form of oral cancer. Symptoms may include a persistent sore throat, difficulty swallowing, changes in speech, and a visible lesion on the tongue. Diagnosis typically involves a biopsy and imaging studies to assess the extent of the disease. Treatment options may include surgery, radiation therapy, and chemotherapy, depending on the stage of the cancer. The prognosis varies based on the tumor's size, location, and whether it has metastasized. Early detection is crucial for improving outcomes, as tongue cancers can be aggressive and may lead to significant morbidity if not treated promptly.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with lesions on the tongue, difficulty swallowing, or unexplained weight loss.
Ensure accurate staging and treatment documentation to support coding.
Thorough examination notes, biopsy results, and surgical reports are essential.
Patients with persistent sore throat or oral lesions requiring surgical intervention.
Document the extent of the disease and any surgical margins involved.
Used when a malignant tumor is surgically excised from the tongue.
Surgical notes detailing the procedure and findings.
Oncologists and otolaryngologists must ensure accurate coding of the excision site.
Common symptoms include a persistent sore or ulcer on the tongue, difficulty swallowing, changes in speech, and unexplained weight loss.
